Tuesday, July 11, 2017 9:55:19 AM
They were not 400k. What I am doing is taking a look at the rate to which the revenues have grown over time along with projections based on the increase revenue from the GEN3 for their current clients as well as the trajectory of Aspire revs increasing. Remember, even though Aspire was included in that large government contract, that does not mean that is all they can do. They can do private as well. The fact that they are a part of it and partnered with KPMG pulls more weight when they are bidding on private contracts as well.
Recent KOAN News
- Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. • Newsfile • 04/08/2026 01:30:00 PM
- MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • GlobeNewswire Inc. • 02/10/2026 03:08:32 PM
- Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc. • Newsfile • 02/10/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc. • Newsfile • 02/06/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue • Newsfile • 01/07/2026 02:30:00 PM
- Apollo Biowellness, Inc., Corporate Status and Merger Update • Newsfile • 10/29/2025 01:30:00 PM
- Apollo Biowellness, Inc., Merger Update • Newsfile • 10/09/2025 06:48:00 PM
- Apollo Biowellness, Inc., Re-Engages GSS Capital • Newsfile • 10/08/2025 01:30:00 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/22/2025 05:22:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/07/2025 05:36:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/16/2025 08:28:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/10/2025 03:41:27 PM
